UltraPlasma™ Multi-Platform Plasma Systems in the Treatment of Seborrheic Dermatitis

Combining Arc, Argon, and Helium Plasmas with Unique Software and Hardware Output Spectrum

Abstract

Seborrheic dermatitis is a chronic, inflammatory skin condition that affects sebum-rich areas such as the scalp, face, and upper trunk. Conventional treatments often struggle to deliver long-term relief without adverse effects. UltraPlasma™ introduces a novel multi-platform plasma treatment system that combines arc, argon, and helium plasmas, enhanced by proprietary software and hardware to produce an optimized output spectrum. This section explores the multi-layered skin interaction of plasma with a focus on gas-phase bioactivity and vascular modulation across the epidermis, dermis, and hypodermis.

1. Introduction to Seborrheic Dermatitis and Plasma Therapy

Seborrheic dermatitis is characterized by erythema, flaking, pruritus, and overproduction of sebum. Recent advancements in cold atmospheric plasma (CAP) applications have enabled non-invasive, pain-free, and micro-selective treatment options. UltraPlasma™ capitalizes on this potential using a synchronized tri-plasma system: Arc (electric discharge), Argon (inert carrier), and Helium (penetrative antioxidant plasma).

4. Clinical Application Protocol

2. UltraPlasma™ System Overview

The UltraPlasma™ system is designed around three core technologies:

• UltraPlasma™ Arc Plasma Mode: Delivers high-density electron energy causing local ionization and production of ozone (O₃), nitric oxide (NO), and reactive oxygen species (ROS) with sebostatic and anti-inflammatory effects.

• UltraPlasma™ Argon Plasma Mode: Facilitates uniform discharge and enhances superficial microcirculation in the dermis. Ideal for vasodilation and oxygenation without causing cellular damage.

• UltraPlasma™ Helium Plasma Mode: Penetrates deeper skin layers with minimal thermal effect, reducing oxidative stress and assisting in barrier repair via nitric oxide and singlet oxygen emissions.

The output spectrum is modulated by proprietary software to maintain therapeutic bandwidths and pulse widths specific to seborrheic dermatosis

3. Biological Mechanisms and Gas Interactions

3.1. Epidermal Effects

• Ozone and NO stimulate keratinocyte turnover.

• Reactive oxygen and nitrogen species (RONS) reduce Malassezia spp. fungal colonies.

• UltraPlasma™ arc plasma’s UV component disrupts microbial DNA/RNA.

3.2. Dermal Functions

• UltraPlasma™ argon plasma improves capillary perfusion and endothelial function.

• Increases oxygen saturation (O₂) in inflammatory regions.

• Promotes fibroblast activity and ECM regeneration.

3.3. Hypodermal Stimulation

• UltraPlasma™ helium plasma reaches adipose-associated vasculature.

• Modulates local immune cells and antioxidant enzyme levels.

• Improves deep lymphatic drainage and detoxification.

Frequency: 2–3 sessions/week Cycle: 4–6 weeks

5. Clinical Results and Observations

Preliminary clinical studies in 32 patients (ages 18–60) showed the following after 4 weeks:

No significant adverse effects reported.
High patient satisfaction and cosmetic compatibility observed.

⌘Conclusion⌘

UltraPlasma™ represents a leap forward in dermatological therapy by combining three plasma technologies into a single, software-optimized system. Its ability to interact with multiple skin layers, stimulate gasotransmitters, and restore physiological function makes it highly effective in managing seborrheic dermatitis. Future clinical trials and bio-markers analysis will further validate and optimize its therapeutic scope.

Shortcut for our Goals!

▼